Literature DB >> 10475982

Hippocampal synaptic plasticity and cognition.

S Akhondzadeh1.   

Abstract

Discoveries made over the past 20 years have greatly improved our understanding of how the brain functions. This article focuses on the relation between memory and cellular mechanisms of neuronal and synaptic plasticity in the hippocampus. Several studies indicate that the hippocampal formation is a crucial element of the neurobiological bases of higher cognitive function. Severe damage to the hippocampal formation is known to produce seemingly permanent anterograde amnesia. A generally accepted hypothesis in neurobiology has been that long-lasting activity-dependent changes in the efficacy of synaptic transmission in the mammalian brain are considered to be of fundamental importance for the development of neural circuitry and for the storage of information. The most compelling and reliable model for such changes has been long-term potentiation (LTP) and long-term depression (LTD) in the hippocampus. Therefore, the possibility of the discovery and development of compounds that, by modulating hippocampal synaptic plasticity, would be useful for the management of dementia and amnesia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10475982     DOI: 10.1046/j.1365-2710.1999.00231.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  16 in total

1.  Vulnerability of welders to manganese exposure--a neuroimaging study.

Authors:  Zaiyang Long; Yue-Ming Jiang; Xiang-Rong Li; William Fadel; Jun Xu; Chien-Lin Yeh; Li-Ling Long; Hai-Lan Luo; Jaroslaw Harezlak; James B Murdoch; Wei Zheng; Ulrike Dydak
Journal:  Neurotoxicology       Date:  2014-03-27       Impact factor: 4.294

2.  A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus.

Authors:  Xiao-lei Zhang; John A Sullivan; Joseph R Moskal; Patric K Stanton
Journal:  Neuropharmacology       Date:  2008-08-29       Impact factor: 5.250

3.  A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders.

Authors:  Elmira Hasanzadeh; Mohammad-Reza Mohammadi; Ahmad Ghanizadeh; Shams-Ali Rezazadeh; Mina Tabrizi; Farzin Rezaei; Shahin Akhondzadeh
Journal:  Child Psychiatry Hum Dev       Date:  2012-10

4.  Impairment of long-term potentiation in the CA1, but not dentate gyrus, of the hippocampus in Obese Zucker rats: role of calcineurin and phosphorylated CaMKII.

Authors:  Korem H Alzoubi; Abdulaziz M Aleisa; Karim A Alkadhi
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  Assay of Calcium Transients and Synapses in Rat Hippocampal Neurons by Kinetic Image Cytometry and High-Content Analysis: An In Vitro Model System for Postchemotherapy Cognitive Impairment.

Authors:  Patrick M McDonough; Natalie L Prigozhina; Ranor C B Basa; Jeffrey H Price
Journal:  Assay Drug Dev Technol       Date:  2017-07       Impact factor: 1.738

6.  A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.

Authors:  Shahin Akhondzadeh; Mehdi Shafiee Sabet; Mohammad Hossein Harirchian; Mansoreh Togha; Hamed Cheraghmakani; Soodeh Razeghi; Seyyed Shamssedin Hejazi; Mohammad Hossein Yousefi; Roozbeh Alimardani; Amirhossein Jamshidi; Shams-Ali Rezazadeh; Aboulghasem Yousefi; Farhad Zare; Atbin Moradi; Ardalan Vossoughi
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

7.  The Importance of Clinical Trials in Drug Development.

Authors:  Shahin Akhondzadeh
Journal:  Avicenna J Med Biotechnol       Date:  2016 Oct-Dec

8.  The Importance of Ethics in Medical Biotechnology.

Authors:  Shahin Akhondzadeh
Journal:  Avicenna J Med Biotechnol       Date:  2015 Jul-Sep

9.  Medical Biotechnology and Alzheimer's Disease: New Hopes.

Authors:  Shahin Akhondzadeh
Journal:  Avicenna J Med Biotechnol       Date:  2016 Apr-Jun

10.  Comprehensive Application of Time-of-flight Secondary Ion Mass Spectrometry (TOF-SIMS) for Ionic Imaging and Bio-energetic Analysis of Club Drug-induced Cognitive Deficiency.

Authors:  Su-Chung Youn; Li-You Chen; Ruei-Jen Chiou; Te-Jen Lai; Wen-Chieh Liao; Fu-Der Mai; Hung-Ming Chang
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.